Program
The event is split up into 3 parts – a scientific symposium with renowned speakers from all over the world, an international best-practices panel, and a celebration and fundraising event in the evening.
Part I: Health Policy and Quality Improvement
Session 1
Welcome Remarks
Niranjan ‘Tex’ Kissoon, President Global Sepsis Alliance, Canada
Konrad Reinhart, Chair Sepsis Stiftung, Germany
Greetings
Tedros Adhanom Ghebreyesus, Director-General, World Health Organization, Switzerland
Karl Lauterbach, Federal Minister of Health, Germany
Achim Steiner, Administrator of the United Nations Development Programme, USA
Ruth Hecker, Chair Coalition for Patient Safety, Germany
The WHO Strategy to Fight Infection-Related Global Health Threats
Zsuzsanna Jakab, Deputy Director‐General World Health Organization, Switzerland
A Husband and Father’s Perspective on Sepsis
Joachim Greuner, Germany
A Sepsis Survivor’s Perspective on Sepsis
Dennis Kredler, European Sepsis Alliance, Belgium
Keynote: Sepsis in the Context of Patient Safety
Ciarán Staunton, End Sepsis – The Legacy of Rory Staunton, USA
Session 2
The Burden of Sepsis, COVID-19, and AMR
Moderated by:
Edmund Neugebauer
Brandenburg Medical School, Germany
Emmanuel Nsutebu
African Sepsis Alliance, United Arab Emirates
12:05h Berlin Time (CEST)
The Global Burden of Sepsis and AMR
Mohsen Naghavi, Institute for Health Metrics and Evaluation, USA
Addressing the Burden of Sepsis in Children Under Five
Niranjan ‘Tex’ Kissoon, Global Sepsis Alliance, Canada
The Burden of Sepsis and COVID-19 in Germany
Carolin Fleischmann‐Struzek, Jena University Hospital, Germany
Sepsis Knowledge – Results from a Representative Survey
Roman Marek, Sepsis Stiftung, Germany
Lunch Break
Session 3
Panel: How to Boost the Implementation of the WHA Sepsis Resolution
Moderated by:
Abdulelah Alhawsawi
Global Sepsis Alliance, Saudi Arabia
Ron Daniels
Global Sepsis Alliance, UK
13:30h Berlin Time (CEST)
Synergies between Pandemic Preparedness, IPC, Sepsis, and AMR
Hanan Balkhy, Assistant Director‐General, World Health Organization, Switzerland
Why Sepsis Needs to Be in the Public and Political Space
Keith Martin, Consortium of Universities for Global Health, USA
The Strategy of WHO Europe in the Fight Against Sepsis
João Breda, Special Adviser at WHO Regional Office for Europe, Greece
Lessons from the Pandemic to Fight Non-COVID Sepsis
Janet Diaz, World Health Organization, Switzerland
WHO HQ Efforts to Improve the Evidence‐Based Management of Sepsis
Teri Reynolds, World Health Organization, Switzerland
Discussion by the panelists
Session 4
Learning by Exchange on the Global, National, and Facility Level
Moderated by:
Bjoern Weiss
Charité University Hospital, Germany
Imrana Malik
Global Sepsis Alliance, USA
14:25h Berlin Time (CEST)
Challenges in Addressing Sepsis in Sub-Saharan Africa
Shevin Jacob, African Sepsis Alliance, Uganda
Australia’s National Action Plan to Fight Sepsis, COVID-19, and AMR
Brett Abbenbroek, Asia Pacific Sepsis Alliance, Australia
Impact of Sepsis Mandates on Patient Outcomes
Marcus Friedrich, BIH/Charité Visiting Professor, USA
Using Synergies to Fight Pandemics, Sepsis, and AMR
Ron Daniels, European Sepsis Alliance, United Kingdom
Lessons Learned by the German Quality Network Sepsis
Daniel Schwarzkopf, Jena University Hospital, Germany
Q&A
Coffee Break
Session 5
Panel: The Challenges of, and Lessons Learned from the Pandemic
Moderated by:
Volkart Wildermuth
Science Journalist, Germany
15:55h Berlin Time (CEST)
Placing Sepsis Prevention and Control Into the WHO Global Context
Rudi Eggers, Director Integrated Health Services, World Health Organization, Switzerland
The Perspective of a Dean and Scientist
Axel Pries, Charité University Hospital, Germany
The Perspective of a Science Editor
Joachim Mueller‐Jung, Frankfurter Allgemeine Zeitung, Germany
The Perspective of a Vaccine Researcher and Developer
Stefan Kaufmann, Max Planck Institute, Germany
The Perspective from Africa and the Eastern Mediterranean Region
Emmanuel Nsutebu, Chair African Sepsis Alliance, United Arab Emirates
Novel Immunomodulatory and Biomarker Approaches in COVID-19 and Sepsis
Evangelos J. Giamarellos‐Bourboulis, Chair European Sepsis Alliance, Greece
On the Importance of and the Barriers to Clinical Research
Tobias Welte, Sepsis Stiftung, Germany
For Evaluating Novel Therapeutics – The Perspective of a Biotech CEO
Niels Riedemann, InflaRx, Germany
Discussion by the panelists
Part II: Panel – Learning from Successful National Sepsis Initiatives
Panel: Learning from Successful National Sepsis Initiatives
Moderated by:
Edmund Neugebauer
Brandenburg Medical School, Germany
Daniel Schwarzkopf
Jena University Hospital, Germany
18:00h Berlin Time (CEST)
The Success Factors of the Surviving Sepsis Campaign on a Global Scale
Mitchell Levy, Brown University, USA
The Challenges and Successes in the Fight Against Sepsis in Latin America
Daniela Carla Souza, Sírio-Libanês Hospital, Brazil
Building a Successful National Sepsis Campaign in Japan
Naoyuki Matsuda, Japanese Sepsis Alliance, Japan
The History and Success Factors for the Sudanese National Sepsis Plan
Mohammed Elfatih Ahmed, Sudanese Sepsis Alliance, Sudan
Background and Impact of the National Clinical Programme on Sepsis Mortality
Michael O‘Dwyer, Health Service Executive, Ireland
History, Achievements, and Future Strategy by Sepsis Alliance in the US
Thomas Heymann, Sepsis Alliance, USA
The Role of Nurses in the National Sepsis QI Initiative in Saudi Arabia
Maha Aljuaid, Global Sepsis Alliance, Saudi Arabia
The Strategy of the MoH-Funded “Germany Recognizes Sepsis”-Coalition
Ellen Heyd, Coalition for Patient Safety, Germany
The SepWiss Project in Berlin and Brandenburg: Strategy and Lessons Learned
Wiltrud Abels, Sepsis Stiftung, Germany
Discussion by the panelists
Part III: Celebration and Fundraising Event
The program for the evening event is available here.